Современная тактика ведения пациентов молодого возраста с синдромом удлиненного интервала QT: от ранней диагностики к имплантации кардиовертера-дефибриллятора и мониторингу маркеров риска внезапной смерти
https://doi.org/10.29001/2073-8552-2015-30-1-28-35
Аннотация
Об авторах
Рукижат Абдул-Гафуровна ИльдароваРоссия
Мария Александровна Школьникова
Россия
Список литературы
1. Бокерия Л.А., Ревишвили А.Ш., Неминущий Н.М. Внезапная сердечная смерть. - М.: Гэотар-Медиа, 2011. - 272 с.
2. Верченко Е.Г., Березницая В.В., Ильдарова Р.А. и др. Electromechanical phenomena associated with congenital long QT syndrome in children // Eur. Heart J. - 2011. - Vol. 32 (Abstract supplement). - P. 1114.
3. Ильдарова Р.А. Роль фенотипической экспрессии в стратификации риска жизнеугрожающих аритмий и оптимизация терапии у детей с различными молекулярно-генетическими вариантами синдрома удлиненного интервала QT: автореф. дис.. канд. мед. наук. - М., 2013. - 17 с.
4. Ильдарова Р.А., Школьникова М.А., Березницкая В.В. и др. Efficacy of ICD therapy in high-risk children with Long QT syndrome // Eur. Heart J. - 2012. - Vol. 33 (Abstract supplement) - P. 4102.
5. Калинин A.A., Ильдарова P.A., Школьникова М.А. Влияние пробы с дозированной физической нагрузкой на функцию синусового узла и реполяризацию у детей с наследственным синдромом удлиненного интервала QT // Кардиология. - 2011. - № 9. - С. 49-56.
6. Калинин Л.А., Школьникова М.А. Метаанализ данных по применению стресс-тестов в диагностике врожденного синдрома удлиненного интервала QT // Вестник аритмологии. - 2013. - № 74. - С. 60-67.
7. Миклашевич И.М., Школьникова М.А., Калинин Л.А. и др. Нормальные значения временных параметров ЭКГ у детей по результатам клинико-эпидемиологического исследования “ЭКГ-скрининг детей и подростков Российской Федерации” // Кардиология. - 2009. - Т. 49, № 10. - С. 47-54.
8. Школьникова М.А. Первичные электрические заболевания сердца как причина внезапной смерти // Доктор. Ру. - 2008. - № 3(40). - С. 25-32.
9. Школьникова М.А., Макаров Л.М., Березницкая В.В. и др. Жизнеугрожающие аритмии и внезапная сердечная смерть у детей // Вестник аритмологии. - 2000. - № 18. - С. 57-58.
10. Школьникова М.А., Харлап М.С., Ильдарова Р.А. Генетически детерминированные нарушения ритма сердца // Рос. кардиологич. журн. - 2011. - №1(87). - С. 8-25.
11. Школьникова М.А., Харлап М.С., Ильдарова Р.А. и др. Диагностика, стратификация риска внезапной смерти и лечение молекулярно-генетических вариантов синдрома удлиненного интервала QT // Кардиология. - 2011. - № 5. - С. 50-61.
12. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death // Circulation. - 2006. - Vol. 114. - P. e385-e484.
13. Ackerman M.J., Khositseth A., Tester D.J. et al. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome // Mayo Clin. Proc. -2002. - Vol. 77. - P. 413-421.
14. Rautaharju P.M., Surawicz B., Gettes L.S. AHA/ACCF/HRS Recommendations for the standardization and interpretation of the electrocardiogram. Part IV: The ST segment, T and U waves, and the QT interval a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society endorsed by the International Society for Computerized Electrocardiology // J. Am. Coll. Cardiol. - 2009. - (Published online Feb. 19, 2009).
15. Aizawa Y., Ueda K., Scornik F et al. Novel mutation in KCNQ1 associated with a potent dominant negative effect as the basis for the LQT1 form of the long QT syndrome // J. Cardiovasc. Electrophysiol. - 2007. - Vol. 18(9). - P. 972-977.
16. Antzelevitch C. The role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes // Am. J. Physiol. Heart Circ. Physiol. - 2007. - Vol. 293(4). -P. H2024-H2038.
17. Bazett H.C. An analysis of the time-relations of electrocardiograms // Heart. - 1920. - Vol. 7. - P. 353-370.
18. Berul C.I. Congenital long QT syndromes: who’s at the risk for sudden cardiac death? // Circulation. - 2008. - Vol. 117. -P. 2178-2180.
19. Besana A., Wang D.W., George A.L. et al. Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome // J. Cardiovasc. Pharmacol. - 2012. - Vol. 59. - P. 249-253.
20. Bos J.M., Bos K.M., Johnson J.N. et al. Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders // CIRCEP.112.000102. - 2013. - 292 p.
21. Chatrath R., Bell C.M., Ackerman M.J. Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome // Pediatr. Cardiol. - 2004. - Vol. 25. - P. 459-465.
22. Chockalingam P., Girardengo G., Johnson J.N. et al. Not all betablockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol // J. Am. Coll. Cardiol. - 2012. - Vol. 60. - P. 2092-2099.
23. Crotti L., Celano G., Dagradi F et al. Congenital long QT syndrome // Orphanet Journal of Rare Diseases. - 2008. -Vol. 3. - P. 18.
24. Crotti L., Spazzolini C., De Ferrari G.M. et al. Is the implantable defibrillator appropriately used in the long QT syndrome? Data from the European Registry // Heart Rhythm. - 2004. - Vol. 1. - S82.
25. Crotti L., Spazzolini C., Schwartz PJ. et al. The common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification // Circulation. - 2007. - Vol. 116. - P. 2366-2375.
26. Dessertene F La tachycardie ventricularie a deux foyer opposes variables // Arch. Mal. Cooeur. - 1966. - Vol. 59. - P. 263-272.
27. Donger C., Denjoy I., Berthet M. et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome // Circulation. - 1997. - Vol. 96. - P. 2778-2781.
28. Expert consensus document on β-adrenergic receptor blockers. The Task Force on Beta-Blockers of the European Society of Cardiology // Eur. Heart J. - 2004. - Vol. 25. - P. 1341-1362.
29. Goldenberg I., Moss A.J., Peterson D.R. et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome // Circulation. - 2008. - Vol. 117. - P. 2184-2191.
30. Hobbs J.B., Peterson D.R., Moss A.J. et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome // JAMA. - 2006. - Vol. 296. - P. 1249-1254.
31. Kim J.A., Lopes C.M., Moss A.J. et al. Trigger-specific risk factors and response to therapy in long QT syndrome type 2 // Heart Rhythm. - 2010. - Vol. 7(12). - P. 1797-1805.
32. Moss A.J., Goldenberg I. Importance of knowing the genotype and the specific mutation when managing patients with long QT syndrome // Circ. Arrhythm. Electrophysiol. - 2008. -Vol. 1. - P. 219-226.
33. Moss A.J., McDonald J. Unilateral cervicothoracic ganglionectomy for the treatment of long QT interval syndrome // N. Engl. J. Med. - 1971. - Vol. 285. - P. 903-904.
34. Moss A.J., Schwartz P.J., Crampton R.S. et al. The long QT syndrome. Prospective longitudinal study of 328 families // Circulation. - 1991. - Vol. 84. - P. 1136-1144.
35. Moss A.J., Shimizu W., Wilde A.A. et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene // Circulation. - 2007. - Vol. 115. - P. 2481-2489.
36. Moss A.J., Shimizu W., Wilde A.A. et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene // Circulation. - 2007. - Vol. 115. - P. 2481-2489.
37. Moss A.J., Zareba W., Hall W.J. et al. Effectiveness and limitations of beta-blocker therapy in congenital long QT syndrome // Circulation. - 2000. - Vol. 101. - P. 616-623.
38. Moss A.J., Zareba W., Kaufman E.S. et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-gogo- related gene potassium channel // Circulation. - 2002. - Vol. 105. - P. 794-799.
39. Noda T., Shimizu M., Satomi K. et al. Classification and mechanism of Torsades de Pointes initiation in patients with congenital long QT syndrome // Eur. Heart J. - 2004. - Vol. 25. - P. 2149-2154.
40. Piippo K., Swan H., Pasternack M. et al. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics // J. Am. Coll. Cardiol. - 2001. - Vol. 37. - P. 562-568.
41. Priori S.G., Antzelevitch C. Inherited arrhythmogenic diseases // Sudden Cardiac Death / edited by S.G. Priori, D.P. Zipes. -Wiley, 2005. - 292 p.
42. Priori S.G., Bloise R., Crotti L. The long QT syndrome // Europace. - 2001. - Vol. 3. - P. 16-27.
43. Priori S.G., Napolitano C., Diehl L., Schwartz P.J. Dispersion of the QT interval: a marker of therapeutic efficacy in the idiopathic long QT syndrome // Circulation. - 1994. - Vol. 89. - P. 1681 1689.
44. Priori S.G., Napolitano C., Schwartz P.J. et al. Association of long QT syndrome loci and cardiac events among patients treated with beta blockers // JAMA. - 2004. - Vol. 292. - P. 1341-1344.
45. Priori S.G., Schwartz P.J., Napolitano C. et al. Risk stratification in the long QT syndrome // N. Engl. J. Med. - 2003. - Vol. 348. - P. 1866-1874.
46. Roden D.M., Lazzara R., Rosen M. et al. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps and future direcrions // Circulation. - 1996. - Vol. 94. - P. 1996-2012.
47. Schwartz P.J. Idiopathic long QT syndrome: progress and questions // Am. Heart J. - 1985. - Vol. 109. - P. 399-411.
48. Schwartz P.J., Priori S.G., Cerrone M. et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long QT syndrome // Circulation. -2004. - Vol. 109. - P. 1826-1833.
49. Schwartz P.J., Priori S.G., Locati E.H. et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate // Circulation. - 1995. - Vol. 92. - P. 3381-3386.
50. Schwartz P.J., Priori S.G., Spazzolini C. et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias // Circulation. - 2001. - Vol. 103. - P. 89-95.
51. Schwartz P.J., Spazzolini C., Priori S.G. et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry // Circulation. - 2010. -Vol. 122. - P. 1272-1282.
52. Schwartz P.J., Verrier R.L., Lown B. Effects of stellectomy and vagotomy on ventricular refractoriness // Circ. Res. - 1977. -Vol. 40. - P. 536-540.
53. Shimizu W., Noda T., Takaki H. et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome // J. Am. Coll. Cardiol. - 2003. - Vol. 41. - P. 633-642.
54. Stramba-Badiale M., Crotti L., Goulene K. et al. Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates // Circulation. - 2007. - Vol. 116 (Abstr. Suppl.). - P. II377.
55. Swan H., Viitasalo M., Piippo K. et al. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects // J. Am. Coll. Cardiol. - 1999. - Vol. 34. - P. 823-829.
56. Takenaka K., Ai T., Shimizu W. et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome // Circulation. - 2003. - Vol. 107(6). - P. 838-844.
57. Towbin J.A., Keating M.T., Priori S.G. et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel // Circulation. - 2002. - Vol. 105. - P. 794-799.
58. Vincent G.M., Fox J., Zhang L. et al. Beta-blockers markedly reduce risk and syncope in KVLQT1 long QT patients // Circulation. - 1996. - Vol. 94 (Suppl. I). - Vol. I-204.
59. Vincent G.M., Zhang L., Timothy K.W. et al. Long QT syndrome patients with normal to borderline prolonged QTc intervals are at risk for syncope, cardiac arrest and sudden death // Circulation. - 1999. - Vol. 100. - P. 1272-1282.
60. Wehrens X.H., Abriel H., Cabo C. et al. Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel б-subunit: a computational analysis // Circulation. - 2000. - Vol. 102. - P. 584-590.
Рецензия
Для цитирования:
Ильдарова Р.А., Школьникова М.А. Современная тактика ведения пациентов молодого возраста с синдромом удлиненного интервала QT: от ранней диагностики к имплантации кардиовертера-дефибриллятора и мониторингу маркеров риска внезапной смерти. Сибирский журнал клинической и экспериментальной медицины. 2015;30(1):28-35. https://doi.org/10.29001/2073-8552-2015-30-1-28-35
For citation:
Ildarova R.A., Shkolnikova M.A. Modern tactics in management of young patients with long QT syndrome: early diagnosis, implantation of cardioverter-defibrillator, and monitoring of sudden cardiac death risk markers. The Siberian Journal of Clinical and Experimental Medicine. 2015;30(1):28-35. (In Russ.) https://doi.org/10.29001/2073-8552-2015-30-1-28-35